Biopolitics for the 21st Century
By Marcy Darnovsky,
2020 Science
| 12. 14. 2009
Much appreciation is due to Andrew for his courage in soliciting "alternative perspectives" on technology innovation and life in the 21st century. I can't help but observe that his nervousness about doing so is one small sign that something is amiss in what he calls "the interface between emerging technologies and society."
One challenge we face in mending that interface is a tendency toward over-enthusiasm about prospective technologies. Another is the entanglement of technology innovation and commercial dynamics. Neither of these is brand new.
Back in the last century, the 1933 Chicago World's Fair took "technological innovation" as its theme and "A Century of Progress" as its formal name. Its official motto was "Science Finds, Industry Applies, Man Conforms."
The slogan shamelessly depicts "science" and "industry" as dictator - or at least drill sergeant - of humanity. It anoints industrial science as a rightful decision-maker about human ends, and an inevitable purveyor of societal uplift.
Today the 1933 World's Fair slogan seems altogether crass. But have we earned our cringe? We'd like to think that we're more realistic about science...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...